Roberto Fattorusso Selected Research

nifenazone

1/2020

Pyrazolones Activate the Proteasome by Gating Mechanisms and Protect Neuronal Cells from β-Amyloid Toxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roberto Fattorusso Research Topics

Disease

10	Neoplasms (Cancer) 09/2022 - 01/2004
4	Neuroblastoma 01/2020 - 03/2011
3	Neoplasm Metastasis (Metastasis) 09/2022 - 01/2013
2	Pathologic Processes 09/2022 - 05/2019
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 09/2022 - 09/2013
2	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2016
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2003
2	Ischemia 01/2018 - 01/2003
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2013 - 01/2003
1	Respiratory Hypersensitivity 09/2022
1	Scrapie 09/2022
1	Insulin Resistance 12/2021
1	Brain Injuries (Brain Injury) 12/2021
1	Hepatocellular Carcinoma (Hepatoma) 09/2020
1	Communicable Diseases (Infectious Diseases) 05/2019
1	Fibrosis (Cirrhosis) 05/2019
1	Inflammation (Inflammations) 05/2019
1	Leukemia 12/2018
1	Infections 01/2018
1	Stroke (Strokes) 01/2018
1	Medulloblastoma 01/2018
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2017
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2017
1	Colonic Neoplasms (Colon Cancer) 12/2016
1	Carcinoma (Carcinomatosis) 12/2016
1	Parkinson Disease (Parkinson's Disease) 03/2015
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2013
1	Pathologic Neovascularization 04/2013
1	Macular Degeneration (Age-Related Maculopathy) 06/2010
1	Anthrax 07/2005
1	Inhalation anthrax 07/2005
1	Autoimmune Diseases (Autoimmune Disease) 07/2005
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2003
1	Epilepsy (Aura) 01/2003

Drug/Important Bio-Agent (IBA)

7	Peptides (Polypeptides)IBA 09/2020 - 01/2004
7	Proteins (Proteins, Gene)FDA Link 09/2020 - 03/2011
3	IntegrinsIBA 09/2022 - 01/2016
3	Cyclophilin AIBA 12/2021 - 01/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2019 - 06/2010
2	Protein Isoforms (Isoforms)IBA 09/2022 - 09/2013
2	Apoptosis Inducing FactorIBA 12/2021 - 01/2017
2	Glutamic Acid (Glutamate)FDA Link 12/2021 - 01/2003
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 05/2013
1	NociceptinIBA 09/2022
1	Lipid NanoparticlesIBA 09/2022
1	Prion ProteinsIBA 09/2022
1	PorphyrinsIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 12/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	Aminopyrine (Aminophenazone)IBA 01/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020
1	nifenazoneIBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 05/2019
1	LigandsIBA 12/2018
1	ChemokinesIBA 12/2018
1	CXC ChemokinesIBA 12/2018
1	Apoptosis Regulatory ProteinsIBA 01/2018
1	thiazolyl blueIBA 12/2016
1	Fluorouracil (Carac)FDA LinkGeneric 12/2016
1	betadex (beta-cyclodextrin)IBA 12/2016
1	pyrimidineIBA 12/2016
1	SynucleinsIBA 03/2015
1	Glycoproteins (Glycoprotein)IBA 09/2013
1	IonsIBA 04/2013
1	MetalsIBA 04/2013
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2013
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2013
1	Cyclic PeptidesIBA 06/2010
1	Metalloproteases (Metalloproteinases)IBA 07/2005
1	Amino Acids FDA Link 07/2005
1	Fc Receptors (Fc Receptor)IBA 07/2005
1	Chelating AgentsIBA 01/2004
1	somatostatin receptor type 1IBA 01/2004
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2004
1	NeurotoxinsIBA 01/2003
1	SodiumIBA 01/2003

Therapy/Procedure

3	Therapeutics 09/2022 - 01/2003
1	Aftercare (After-Treatment) 03/2011
1	Emergency Treatment 07/2005